N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to find out whether N10 chemotherapy is a safe and effective treatment for children with high-risk neuroblastoma.
Epistemonikos ID: 22ef2998d7cb1918b095d366a5f0c52371f5362b
First added on: Aug 01, 2024